These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 19398944)
1. The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer. Fuchsjäger M; Akin O; Shukla-Dave A; Pucar D; Hricak H Clin Adv Hematol Oncol; 2009 Mar; 7(3):193-202. PubMed ID: 19398944 [TBL] [Abstract][Full Text] [Related]
2. Functional magnetic resonance imaging in prostate cancer. Seitz M; Shukla-Dave A; Bjartell A; Touijer K; Sciarra A; Bastian PJ; Stief C; Hricak H; Graser A Eur Urol; 2009 Apr; 55(4):801-14. PubMed ID: 19185981 [TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging and magnetic resonance spectroscopic imaging of prostate cancer. Huzjan R; Sala E; Hricak H Nat Clin Pract Urol; 2005 Sep; 2(9):434-42. PubMed ID: 16474681 [TBL] [Abstract][Full Text] [Related]
4. [1H magnetic resonance spectroscopy of the prostate]. Mueller-Lisse UG; Scherr M Radiologe; 2003 Jun; 43(6):481-8. PubMed ID: 12827263 [TBL] [Abstract][Full Text] [Related]
5. MR imaging and MR spectroscopy in prostate cancer management. Katz S; Rosen M Radiol Clin North Am; 2006 Sep; 44(5):723-34, viii. PubMed ID: 17030223 [TBL] [Abstract][Full Text] [Related]
6. Prostate cancer: value of magnetic resonance spectroscopy 3D chemical shift imaging. Casciani E; Gualdi GF Abdom Imaging; 2006; 31(4):490-9. PubMed ID: 16955379 [TBL] [Abstract][Full Text] [Related]
7. MR-guided interventions for prostate cancer. Atalar E; Ménard C Magn Reson Imaging Clin N Am; 2005 Aug; 13(3):491-504. PubMed ID: 16084415 [TBL] [Abstract][Full Text] [Related]
11. Update of prostate magnetic resonance imaging at 3 T. Kim CK; Park BK J Comput Assist Tomogr; 2008; 32(2):163-72. PubMed ID: 18379296 [TBL] [Abstract][Full Text] [Related]
12. Spectroscopy in prostate cancer: hope or hype? Roach M; Kurhanewicz J; Carroll P Oncology (Williston Park); 2001 Nov; 15(11):1399-410; discussion 1415-6, 1418. PubMed ID: 11758871 [TBL] [Abstract][Full Text] [Related]
13. MRI of the prostate: clinical relevance and emerging applications. Mazaheri Y; Shukla-Dave A; Muellner A; Hricak H J Magn Reson Imaging; 2011 Feb; 33(2):258-74. PubMed ID: 21274967 [TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance spectroscopic imaging: current status in the management of prostate cancer. Nayyar R; Kumar R; Kumar V; Jagannathan NR; Gupta NP; Hemal AK BJU Int; 2009 Jun; 103(12):1614-20. PubMed ID: 19338548 [TBL] [Abstract][Full Text] [Related]
15. Editorial comment on: role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Hara N Eur Urol; 2008 Sep; 54(3):598-9. PubMed ID: 18226440 [No Abstract] [Full Text] [Related]
16. Editorial comment on: role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Fütterer JJ; Barentsz JO Eur Urol; 2008 Sep; 54(3):599-600. PubMed ID: 18226439 [No Abstract] [Full Text] [Related]